Squarepoint Ops LLC United Therapeutics Corp Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Squarepoint Ops LLC holds 7,700 shares of UTHR stock, worth $2.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,700

Previous 12,900 40.31%

Holding current value

$2.87 Million

Previous $4.11 Million 32.85%

% of portfolio

0.0%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$210.76 - $249.51 $33.2 Million - $39.3 Million	157,321 Added 779.59%	177,501 $40.8 Million
Q4 2023 Feb 14, 2024	SELL	$214.88 - $256.94 $5.27 Million - $6.3 Million	-24,513 Reduced 54.85%	20,180 $4.44 Million
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $8.27 Million - $9.39 Million	40,295 Added 916.21%	44,693 $9.87 Million
Q1 2023 May 15, 2023	SELL	$212.99 - $276.17 $422,572 - $547,921	-1,984 Reduced 31.09%	4,398 $984,000
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $1.31 Million - $1.79 Million	6,382 New	6,382 $1.77 Million
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $1.5 Million - $2.06 Million	-8,562 Reduced 44.68%	10,600 $2.5 Million
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $271,006 - $348,968	-1,631 Reduced 7.84%	19,162 $3.44 Million
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $3.17 Million - $3.72 Million	-17,194 Reduced 45.26%	20,793 $4.49 Million
Q3 2021 Nov 15, 2021	BUY	$179.86 - $214.88 $1.18 Million - $1.41 Million	6,563 Added 20.89%	37,987 $7.01 Million
Q2 2021 Aug 16, 2021	BUY	$170.47 - $211.93 $699,438 - $869,548	4,103 Added 15.02%	31,424 $5.64 Million
Q1 2021 May 17, 2021	BUY	$153.94 - $174.85 $2.26 Million - $2.57 Million	14,681 Added 116.15%	27,321 $4.57 Million
Q4 2020 Feb 16, 2021	SELL	$101.87 - $151.79 $540,114 - $804,790	-5,302 Reduced 29.55%	12,640 $1.92 Million
Q3 2020 Nov 16, 2020	BUY	$99.9 - $121.13 $1.21 Million - $1.46 Million	12,069 Added 205.5%	17,942 $1.81 Million
Q2 2020 Aug 14, 2020	SELL	$92.74 - $125.82 $4.11 Million - $5.57 Million	-44,304 Reduced 88.3%	5,873 $711,000
Q1 2020 May 15, 2020	SELL	$79.39 - $115.35 $5.67 Million - $8.23 Million	-71,380 Reduced 58.72%	50,177 $4.76 Million
Q4 2019 Feb 14, 2020	BUY	$78.31 - $95.34 $215,117 - $261,898	2,747 Added 2.31%	121,557 $10.7 Million
Q3 2019 Nov 14, 2019	BUY	$74.85 - $85.99 $7.01 Million - $8.06 Million	93,707 Added 373.29%	118,810 $9.48 Million
Q2 2019 Aug 14, 2019	SELL	$76.06 - $120.81 $848,145 - $1.35 Million	-11,151 Reduced 30.76%	25,103 $1.96 Million
Q1 2019 May 15, 2019	BUY	$107.15 - $126.84 $3.88 Million - $4.6 Million	36,254 New	36,254 $4.26 Million
Q4 2018 Feb 14, 2019	SELL	$101.4 - $128.73 $1.98 Million - $2.52 Million	-19,566 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$113.81 - $129.46 $2.23 Million - $2.53 Million	19,566 New	19,566 $2.5 Million
Q2 2018 Aug 14, 2018	SELL	$101.14 - $118.31 $317,883 - $371,848	-3,143 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$107.21 - $151.94 $2.77 Million - $3.92 Million	-25,799 Reduced 89.14%	3,143 $353,000
Q4 2017 Feb 14, 2018	BUY	$118.58 - $151.28 $2.18 Million - $2.78 Million	18,344 Added 173.09%	28,942 $4.28 Million
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $1.21 Million - $1.45 Million	10,598	10,598 $1.24 Million

Others Institutions Holding UTHR

# of Institutions

669

Shares Held

42.8M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC United Therapeutics Corp Transaction History